Literature DB >> 19181736

Point: use of pharmacogenetics in guiding treatment with warfarin.

Mia Wadelius1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19181736     DOI： 10.1373/clinchem.2008.115964

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  5 in total

1.  Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.

Authors:  Sherif M M Ekladious; Marianne Samir M Issac; Sahar Abd El-Atty Sharaf; Hazem S Abou-Youssef
Journal:  Mol Diagn Ther       Date:  2013-12       Impact factor: 4.074

2.  Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients.

Authors:  Joyce H S You; Raymond S M Wong; Mary M Y Waye; Yawei Mu; Cadmon K Lim; Kai-Chow Choi; Gregory Cheng
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

3.  Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes.

Authors:  Isa Ivette Valentin; Joan Vazquez; Giselle Rivera-Miranda; Richard L Seip; Meredith Velez; Mohan Kocherla; Kali Bogaard; Iadelisse Cruz-Gonzalez; Carmen L Cadilla; Jessica Y Renta; Juan F Feliu; Alga S Ramos; Yirelia Alejandro-Cowan; Krystyna Gorowski; Gualberto Ruaño; Jorge Duconge
Journal:  Ann Pharmacother       Date:  2012-01-24       Impact factor: 3.154

4.  Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians.

Authors:  Ivet M Suriapranata; Wen Ye Tjong; Tingliang Wang; Andi Utama; Sunu B Raharjo; Yoga Yuniadi; Susan Sw Tai
Journal:  BMC Med Genet       Date:  2011-06-06       Impact factor: 2.103

5.  Application of personalized medicine to chronic disease: a feasibility assessment.

Authors:  Ruslan Dorfman; Zayna Khayat; Tammy Sieminowski; Brian Golden; Renee Lyons
Journal:  Clin Transl Med       Date:  2013-12-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.